Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XL STROKE: A Nationwide Prospective Registry of Endovascular Thrombectomy for Extra-large Ischemic Stroke With Large Vessel Occlusion

NCT06210633 is registered in ClinicalTrials.gov with Zhongming Qiu as lead sponsor.

NCT NCT06210633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06210633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XL STROKE: A Nationwide Prospective Registry of Endovascular Thrombectomy for Extra-large Ischemic Stroke With Large Vessel Occlusion
Lead sponsor
Zhongming Qiu
Phase
Observational
Overall status
Recruiting
Start date
January 20, 2024
Completion date
March 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke (ais), acute ischemic stroke from large vessel occlusion